Annual D&A
$9.53M$2.36M-19.85%
Summary
- Current Value
- As of today, CYTK annual D&A is $9.53M, down -19.85% on
- Historical Performance
- CYTK annual D&A is down -1.10% over the past 3 years, and up +637.12% over the past 5 years
- All-Time High Comparison
- CYTK annual D&A is currently -19.85% below its historical high of $11.89M set on
- 3-Year Low Comparison
- CYTK annual D&A is +13.48% above its 3-year low of $8.40M reached on an earlier date
- Sector Comparison
- CYTK annual D&A is higher than 71.66% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $9.53M | -19.9% | -1.1% | +637.1% | +371.6% | |
| Quarterly D&A | $2.68M | +11.1% | +28.3% | +399.8% | +468.8% | |
| TTM D&A | $9.65M | -28.4% | +15.6% | +450.9% | +399.6% | |
| Price | $64.11 | +35.3% | +51.6% | +197.5% | +418.7% | |
| Annual SG&A | $215.31M | +24.0% | +122.4% | +443.6% | +1277.9% | |
| Annual Total Expenses | $554.72M | +10.1% | +116.1% | +341.2% | +900.1% | |
| Annual Operating Expenses | $215.31M | +24.0% | +122.4% | +443.6% | +288.2% | |
| Annual Revenue | $18.47M | +145.3% | -73.8% | -31.2% | -77.3% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.89M | -19.9% | |
| 5Y | $11.89M | -19.9% | |
| All | $11.89M | -19.9% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.40M | N/A | +13.5% |
| 5Y | $1.83M | N/A | +420.5% |
| All | $433.00K | +2101.2% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of CYTK?
As of today, CYTK annual D&A is $9.53M
What is 1-year change in CYTK annual D&A?
CYTK annual D&A is down -19.85% year-over-year
What is 3-year change in CYTK annual D&A?
CYTK annual D&A is down -1.10% over the past 3 years
How far is CYTK annual D&A from its all-time high?
CYTK annual D&A is currently -19.85% below its historical high of $11.89M set on December 31, 2023
How does CYTK annual D&A rank versus sector peers?
CYTK annual D&A is higher than 71.66% of companies in Healthcare sector
When is CYTK next annual earnings release?
The next annual earnings release for CYTK is on
Quarterly D&A
$2.68M$394.00K+17.24%
Summary
- Current Value
- As of today, CYTK quarterly D&A is $2.68M, up +17.24% on
- Historical Performance
- CYTK quarterly D&A is up +11.12% year-over-year, and up +28.30% over the past 3 years
- All-Time High Comparison
- CYTK quarterly D&A is currently -57.71% below its historical high of $6.34M set on
- 3-Year Low Comparison
- CYTK quarterly D&A is +15858.82% above its 3-year low of -$17.00K reached on
- Sector Comparison
- CYTK quarterly D&A is higher than 69.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $2.68M | +17.2% | +11.1% | +28.3% | +399.8% | |
| Annual D&A | $9.53M | – | -19.9% | -1.1% | +637.1% | |
| TTM D&A | $9.65M | +2.9% | -28.4% | +15.6% | +450.9% | |
| Price | $64.11 | +6.3% | +35.3% | +51.6% | +197.5% | |
| Quarterly SG&A | $69.46M | +5.7% | +22.6% | +44.0% | +464.6% | |
| Quarterly Total Expenses | $308.11M | +53.2% | +91.4% | +112.8% | +586.8% | |
| Quarterly Operating Expenses | $166.01M | -5.7% | +19.6% | +52.5% | +3302.4% | |
| Quarterly Revenue | $1.94M | -97.1% | +318.1% | -23.0% | -95.4% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.68M | at high | |
| 3Y | $6.34M | -57.7% | |
| 5Y | $6.34M | -57.7% | |
| All | $6.34M | -57.7% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.29M | +17.2% | |
| 3Y | -$17.00K | >+9999.0% | |
| 5Y | -$17.00K | >+9999.0% | |
| All | -$320.00K | +937.2% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of CYTK?
As of today, CYTK quarterly D&A is $2.68M
What is CYTK quarterly D&A most recent change?
CYTK quarterly D&A was up +17.24% on September 30, 2025
What is 1-year change in CYTK quarterly D&A?
CYTK quarterly D&A is up +11.12% year-over-year
How far is CYTK quarterly D&A from its all-time high?
CYTK quarterly D&A is currently -57.71% below its historical high of $6.34M set on December 31, 2023
How does CYTK quarterly D&A rank versus sector peers?
CYTK quarterly D&A is higher than 69.84% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
TTM D&A
$9.65M$268.00K+2.86%
Summary
- Current Value
- As of today, CYTK TTM D&A is $9.65M, up +2.86% on
- Historical Performance
- CYTK TTM D&A is down -28.45% year-over-year, and up +15.59% over the past 3 years
- All-Time High Comparison
- CYTK TTM D&A is currently -28.45% below its historical high of $13.48M set on
- 3-Year Low Comparison
- CYTK TTM D&A is +16.26% above its 3-year low of $8.30M reached on
- Sector Comparison
- CYTK TTM D&A is higher than 68.97% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $9.65M | +2.9% | -28.4% | +15.6% | +450.9% | |
| Annual D&A | $9.53M | – | -19.9% | -1.1% | +637.1% | |
| Quarterly D&A | $2.68M | +17.2% | +11.1% | +28.3% | +399.8% | |
| Price | $64.11 | +6.3% | +35.3% | +51.6% | +197.5% | |
| TTM SG&A | -$11.87B | -5001.7% | -6120.6% | -7619.0% | -10000.0% | |
| TTM Revenue | $87.21M | +1.7% | +2609.3% | -41.2% | +60.6% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.65M | at high | |
| 3Y | $13.48M | -28.4% | |
| 5Y | $13.48M | -28.4% | |
| All | $13.48M | -28.4% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.38M | +2.9% | |
| 3Y | $8.30M | +16.3% | |
| 5Y | $1.83M | N/A | +426.9% |
| All | $414.00K | +2230.2% |
TTM D&A History
FAQ
What is the current TTM D&A of CYTK?
As of today, CYTK TTM D&A is $9.65M
What is CYTK TTM D&A most recent change?
CYTK TTM D&A was up +2.86% on September 30, 2025
What is 1-year change in CYTK TTM D&A?
CYTK TTM D&A is down -28.45% year-over-year
How far is CYTK TTM D&A from its all-time high?
CYTK TTM D&A is currently -28.45% below its historical high of $13.48M set on September 30, 2024
How does CYTK TTM D&A rank versus sector peers?
CYTK TTM D&A is higher than 68.97% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061983/000119312525267059/0001193125-25-267059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk